Zebra Technologies
ZBRA Nasdaq Electronic Equipment & Instruments Financials FY2016βFY2025
Zebra Technologies' revenue rose 8.3% to $5.4 billion in fiscal 2025. Its operating margin was 13.0%, down from 14.9% a year earlier. Free cash flow was $831 million, down 12.9%. It paid out $587 million in dividends and buybacks, 71% of free cash flow. The diluted share count fell 1.3%.
What Zebra Technologies does
No business description yet.
- Legal name
- Zebra Technologies Corporation
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-007668
0000877212
Revenue and margins
Zebra Technologies had $5.4B of revenue in fiscal 2025, up 8.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $831M in fiscal 2025, 15.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Zebra Technologies returned $587M to shareholders in fiscal 2025, 71% of free cash flow. The diluted share count fell 1.3%.
Value Zebra Technologies yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$2.4B and divides by 51.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 35.3x Β· peers 23.4x Β· sector 33.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Zebra Technologies can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $332M | $105M | $137M | $901M | $125M |
| Debt incl. finance leases | $991M | $2.0B | $2.2B | $2.2B | $2.5B |
| Net debt / EBITDA | 0.6x | 2.6x | 3.2x | 1.4x | 2.7x |
| Debt / equity | 0.3x | 0.7x | 0.7x | 0.6x | 0.7x |
| Interest coverage | 195.8x | 9.1x | 4.3x | 13.5x | 5.4x |
| Current ratio | 0.9x | 0.8x | 1.1x | 1.4x | 1.0x |
| Quick ratio | 0.7x | 0.4x | 0.5x | 1.0x | 0.6x |
| Total assets | $6.2B | $7.5B | $7.3B | $8.0B | $8.5B |
| Total liabilities | $3.2B | $4.8B | $4.3B | $4.4B | $4.9B |
| Shareholders' equity | $3.0B | $2.7B | $3.0B | $3.6B | $3.6B |
| Net debt (β = net cash) | $659M | $1.9B | $2.1B | $1.3B | $2.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.4M
1 insider
Sold, 12 months
$2.4M
6 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Linda ConnlyDirector | Sold | 500 | $377.68 | $0.2M | Form 4 |
| Aug 7, 2026 | Michael ChoChief Strategy Officer | Sold | 3,500 | $375.20 | $1.3M | Form 4 |
| May 26, 2026 | Loizides Melissa LuffChief People Officer | Sold | 500 | $253.95 | $0.1M | Form 4 |
| May 14, 2026 | Janice M RobertsDirector | Sold | 3,000 | $249.54 | $0.7M | Form 4 |
| Mar 12, 2026 | Satish DhanasekaranDirector | Bought | 200 | $205.40 | $0.0M | Form 4 |
| Mar 5, 2026 | Cristen L KoglChief Legal Officer | Sold | 145 | $235.71 | $0.0M | Form 4 |
| Mar 5, 2026 | Robert John Armstrong JrChief Marketing Officer | Sold | 9 | $229.73 | $0.0M | Form 4 |
| Feb 27, 2026 | Satish DhanasekaranDirector | Bought | 500 | $225.25 | $0.1M | Form 4 |
| Nov 18, 2025 | Satish DhanasekaranDirector | Bought | 1,000 | $233.12 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 4 / 9 | 8 / 9 | 4 / 9 |
| Accruals ratio | 4.0% | β6.4% | β6.1% |
| Altman Z'' | 3.19 | 4.08 | 3.30 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Zebra Technologies ZBRA | $18.6B | 8.3% | 13.0% | 15.4% | 9.7% | 35.3x | 4 | |
| Keysight Technologies KEYS | $54.5B | 8.0% | 16.3% | 23.8% | 12.1% | 43.1x | 6 | Compare β |
| Teledyne Technologies TDY | $29.3B | 7.9% | 18.8% | 17.6% | 7.8% | 28.6x | 7 | Compare β |
| Roper Technologies ROP | $44.1B | 12.3% | 28.3% | 31.6% | 6.4% | 18.2x | 5 | Compare β |
| Vontier VNT | $4.8B | 3.2% | 18.3% | 14.3% | 15.8% | 14.2x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.6B | $3.7B | $4.2B | $4.5B | $4.4B | $5.6B | $5.8B | $4.6B | $5.0B | $5.4B |
| Gross profit | $1.6B | $1.7B | $2.0B | $2.1B | $2.0B | $2.6B | $2.6B | $2.1B | $2.4B | $2.6B |
| Research and development | $376M | $389M | $444M | $447M | $453M | $567M | $570M | $519M | $563M | $593M |
| Operating income | $80.0M | $322M | $610M | $692M | $651M | $979M | $529M | $481M | $742M | $700M |
| Interest expense | $193M | $227M | $91.0M | $89.0M | $76.0M | $5.0M | $58.0M | $111M | $55.0M | $129M |
| Pretax income | β$129M | $88.0M | $524M | $598M | $560M | $968M | $544M | $334M | $635M | $560M |
| Income tax | $8.0M | $71.0M | $103M | $54.0M | $56.0M | $131M | $81.0M | $38.0M | $107M | $141M |
| Net income | β$137M | $17.0M | $421M | $544M | $504M | $837M | $463M | $296M | $528M | $419M |
| Diluted EPS | β$2.65 | $0.32 | $7.76 | $9.97 | $9.35 | $15.52 | $8.80 | $5.72 | $10.18 | $8.18 |
| Diluted shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $380M | $478M | $785M | $685M | $962M | $1.1B | $488M | β$4.0M | $1.0B | $917M |
| Capital expenditure | $77.0M | $50.0M | $64.0M | $61.0M | $67.0M | $59.0M | $75.0M | $87.0M | $59.0M | $86.0M |
| Free cash flow | $303M | $428M | $721M | $624M | $895M | $1.0B | $413M | β$91.0M | $954M | $831M |
| Depreciation and amortization | $304M | $263M | $175M | $175M | $146M | $187M | $204M | $176M | $172M | $185M |
| Stock-based compensation | $27.0M | $35.0M | $45.0M | $48.0M | $51.0M | $76.0M | $88.0M | $55.0M | $89.0M | $163M |
| Acquisitions | $0.0M | $0.0M | $72.0M | $262M | $548M | $452M | $881M | $0.0M | $0.0M | $1.4B |
| Share buybacks | $0.0M | $0.0M | $0.0M | $47.0M | $200M | $57.0M | $751M | $52.0M | $47.0M | $587M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $0.0M | $0.0M | $47.0M | $200M | $57.0M | $751M | $52.0M | $47.0M | $587M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $156M | $62.0M | $44.0M | $30.0M | $168M | $332M | $105M | $137M | $901M | $125M |
| Total debt | $2.6B | $2.2B | $1.6B | $266M | $1.2B | $991M | $2.0B | $2.2B | $2.2B | $2.5B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $1.2B | $1.1B | $1.2B | $1.2B | $1.3B | $1.7B | $1.9B | $1.7B | $2.4B | $1.8B |
| Current liabilities | $949M | $1.0B | $1.3B | $1.4B | $1.9B | $1.8B | $2.3B | $1.6B | $1.7B | $1.9B |
| Inventory | $345M | $458M | $520M | $474M | $511M | $491M | $860M | $804M | $693M | $729M |
| Property and equipment, net | $292M | $264M | $249M | $259M | $274M | $272M | $278M | $309M | $305M | $353M |
| Total assets | $4.6B | $4.3B | $4.3B | $4.7B | $5.4B | $6.2B | $7.5B | $7.3B | $8.0B | $8.5B |
| Total liabilities | $3.8B | $3.4B | $3.0B | $2.9B | $3.2B | $3.2B | $4.8B | $4.3B | $4.4B | $4.9B |
| Shareholders' equity | $792M | $834M | $1.3B | $1.8B | $2.1B | $3.0B | $2.7B | $3.0B | $3.6B | $3.6B |
| Margins | ||||||||||
| Gross margin | 45.9% | 45.9% | 47.0% | 46.8% | 45.0% | 46.7% | 45.4% | 46.3% | 48.4% | 48.1% |
| Operating margin | 2.2% | 8.7% | 14.5% | 15.4% | 14.6% | 17.4% | 9.2% | 10.5% | 14.9% | 13.0% |
| EBITDA margin | 10.7% | 15.7% | 18.6% | 19.3% | 17.9% | 20.7% | 12.7% | 14.3% | 18.4% | 16.4% |
| Net margin | β3.8% | 0.5% | 10.0% | 12.1% | 11.3% | 14.9% | 8.0% | 6.5% | 10.6% | 7.8% |
| FCF margin | 8.5% | 11.5% | 17.1% | 13.9% | 20.1% | 18.0% | 7.1% | β2.0% | 19.2% | 15.4% |
| Returns | ||||||||||
| Return on capital | 1.8% | 5.2% | 16.8% | 25.4% | 22.1% | 24.7% | 10.9% | 8.7% | 12.4% | 9.7% |
| Return on capital employed | 2.0% | 9.3% | 19.3% | 21.8% | 19.1% | 24.7% | 11.0% | 8.8% | 12.4% | 10.8% |
| Return on equity | β16.3% | 2.1% | 38.8% | 34.3% | 25.3% | 32.6% | 16.2% | 10.3% | 16.0% | 11.7% |
| Return on assets | β2.8% | 0.4% | 9.8% | 12.0% | 10.0% | 14.4% | 6.7% | 4.0% | 6.9% | 5.1% |
| Growth | ||||||||||
| Revenue growth | β2.1% | 4.1% | 13.3% | 6.3% | β0.8% | 26.5% | 2.7% | β20.7% | 8.7% | 8.3% |
| Net income growth | β | β | 2,376.5% | 29.2% | β7.4% | 66.1% | β44.7% | β36.1% | 78.4% | β20.6% |
| EPS growth | β | β | 2,325.0% | 28.5% | β6.2% | 66.0% | β43.3% | β35.0% | 78.0% | β19.7% |
| FCF growth | β | 41.3% | 68.5% | β13.5% | 43.4% | 12.9% | β59.1% | β122.0% | β | β12.9% |
| Share count change | 1.1% | 4.1% | 1.1% | 0.5% | β1.3% | β0.0% | β2.5% | β1.6% | 0.3% | β1.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 6.5x | 3.6x | 2.0x | 0.3x | 1.4x | 0.6x | 2.6x | 3.2x | 1.4x | 2.7x |
| Debt / equity | 3.3x | 2.6x | 1.2x | 0.1x | 0.6x | 0.3x | 0.7x | 0.7x | 0.6x | 0.7x |
| Interest coverage | 0.4x | 1.4x | 6.7x | 7.8x | 8.6x | 195.8x | 9.1x | 4.3x | 13.5x | 5.4x |
| Current ratio | 1.3x | 1.1x | 0.9x | 0.9x | 0.7x | 0.9x | 0.8x | 1.1x | 1.4x | 1.0x |
| Quick ratio | 0.9x | 0.6x | 0.5x | 0.5x | 0.4x | 0.7x | 0.4x | 0.5x | 1.0x | 0.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.2% | 1.3% | 1.5% | 1.4% | 1.5% | 1.1% | 1.3% | 1.9% | 1.2% | 1.6% |
| Stock comp / revenue | 0.8% | 0.9% | 1.1% | 1.1% | 1.2% | 1.4% | 1.5% | 1.2% | 1.8% | 3.0% |
| Payouts / FCF | 0.0% | 0.0% | 0.0% | 7.5% | 22.4% | 5.6% | 181.8% | β | 4.9% | 70.6% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 7.0 | 7.0 | 6.0 | 4.0 | 9.0 | 4.0 | 4.0 | 8.0 | 4.0 |
| Altman Z'' | 1.6 | 1.8 | 2.5 | 2.9 | 2.5 | 3.8 | 2.4 | 3.2 | 4.1 | 3.3 |
| Accruals ratio | β10.7% | β10.4% | β8.5% | β3.1% | β9.1% | β4.0% | β0.4% | 4.0% | β6.4% | β6.1% |
Source: SEC EDGAR XBRL filings (CIK 0000877212). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.